Dualitas Therapeutics

South San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a bispecific antibody therapeutics platform designed for addressing immunology and inflammation. Dualitas Therapeutics is based in South San Francisco, CA and was founded in 2023. It was valued at $87 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $65 million across 1 recorded round; the latest was a $32.6 million early-stage round in Jul 2025.

PMV mark · valuation
$87.0M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$65.0M
Last round
Early Stage VC
Jul 2025

Who backs Dualitas Therapeutics?

6 investors
InvestorType
Qiming Venture PartnersVenture capital
Alexandria Venture InvestmentsOther
SV Health InvestorsVenture capital
Versant VenturesVenture capital
Chugai Venture Fund—
Eli Lilly—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Dualitas Therapeutics investors

6 investors are on record for Dualitas Therapeutics, including Qiming Venture Partners, Alexandria Venture Investments, SV Health Investors and Versant Ventures. The early-stage round in Jul 2025 drew 7 investors.

Free account
More of Dualitas Therapeutics with a free account
  • ·Watch Dualitas Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Dualitas Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View